These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 1421235

  • 21. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
    Umezawa S, Takeshima N, Shimizu Y, Hasumi K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
    Petrov SV, Mazurenko NN, Sukhova NM, Moroz IP, Katsenel'son VM, Raĭkhlin NT, Kiselev FL.
    Arkh Patol; 1994 Feb; 56(4):22-31. PubMed ID: 7848100
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y, Ueda G, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Nishino T, Saito J, Abe Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Immunohistological evaluation of the cancer associate antigen (TA-4) for pathoclinical management of the cervical malignancy].
    Kimura A, Shibata K, Hoshina M, Maruo T, Mochizuki M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec 20; 19(10):2248-54. PubMed ID: 6533207
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunohistochemical detection of Ca antigen in normal, dysplastic and neoplastic squamous epithelia of the human uterine cervix.
    Lloyd JM, O'Dowd T, Driver M, Tee DE.
    J Clin Pathol; 1984 Jan 20; 37(1):14-9. PubMed ID: 6368596
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Comment on the article "Immunologic aspects of invasive squamous cell carcinoma of the cervix uteri"].
    Fuith LC, Hetzel H, Reibnegger G, Wachter H, Dapunt O.
    Geburtshilfe Frauenheilkd; 1988 Jun 20; 48(6):466-7. PubMed ID: 3262073
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
    Gosselin P, Cazin JL, Dehaut JP, Sulman C, Baranzelli MC, Demaille MC.
    Presse Med; 1987 Oct 17; 16(34):1677-9. PubMed ID: 2959941
    [Abstract] [Full Text] [Related]

  • 38. [Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervix].
    Ueda M, Maeda T, Yamada T, Miyawaki Y, Otsuki Y, Okamoto Y, Okamura S, Sano T, Ueki M, Sugimoto O.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul 17; 38(7):1071-8. PubMed ID: 3746026
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.